Leading article: Drugs companies, heal thyselves

 

Share
Related Topics

Research suggesting that the vast majority of the new drugs launched by pharmaceutical companies are only tweaked versions of old ones, with little – if any – improvement in therapeutic effect, cannot but be alarming. The good news, however, is that there is a solution, or at least the start of one, if regulators are prepared to be brave.

Drug companies have any number of explanations for the "innovation crisis" that is severely hampering the development of new drug treatments. After decades of intensive research and development, they say, many of the most obvious discoveries have been made; not only is finding different "agents" therefore becoming steadily more difficult, but there are, anyway, proven benefits to iterative progress. Meanwhile, ever more onerous regulations are pushing up developers' costs, putting a price tag of as much as £1bn on bringing a new product to the market. And with many early patents now running out, companies' incomes are simultaneously being squeezed.

All are claims with which some outside the industry quibble. As the research reported in this newspaper today points out, development costs may indeed have risen sharply in recent years, but revenues have shot up far faster and the majority of spending is absorbed by marketing budgets. Hardly a constructive state of affairs. But even if the drug companies' excuses are justified, it would make no difference. The need to change the market incentives to encourage entirely new – more effective – treatments remains.

One proposal is that drug makers be asked to demonstrate that their product works better than those already available, rather than simply better than a placebo. That would certainly be a start. It would also be useful for the prices paid by government buyers – the NHS being an obvious example – to be more closely tied to effectiveness rather than abstruse capital returns calculations.

Signs that watchdogs in both Europe and the US are looking at reforms are welcome. But with the pharmaceutical market barely fit for purpose, it is time to stop talking and start doing.

React Now

Latest stories from i100
iJobs Job Widget
iJobs General

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Guru Careers: Software Developer

£35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

SThree: Trainee Recruitment Consultant / Resourcer

£18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

£25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

Day In a Page

Read Next
New SNP MP Mhairi Black distinguished herself in Westminster straight away when she made herself a chip butty in the canteen  

The SNP adventure arrives in Westminister - but how long before these new MPs go native?

Katy Guest
The Public Accounts Committee found widespread concern among civil servants that they would be victimised if they spoke out about wrongdoing  

Nikileaks explained: The sad thing about the Nicola Sturgeon saga is that it makes leaks less likely

Jane Merrick
Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

Laughter, but no tears, as Letterman takes his bow after 33 years

Veteran talkshow host steps down to plaudits from four presidents
Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

Hozier's 'blasphemous' song takes Novello award

Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

Join the tequila gold rush

The spirit has gone from a cheap shot to a multi-billion pound product
12 best statement wallpapers

12 best statement wallpapers

Make an impact and transform a room with a conversation-starting pattern
Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

Paul Scholes column

Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?